Removing inactive NRTIs in a salvage regimen is safe, maintains virological suppression and reduces treatment costs: results from the VERITAS study (TMC114HIV4054).

Benoit TrottierChrissi GalanakisDanièle LongpréHarold DionSylvie VézinaStéphane LavoieMichel BoissonnaultCecilia CostiniukMohammad-Ali JenabianNimâ MachoufRéjean Thomas

Published in: HIV clinical trials (2018)

Removing inactive NRTIs in patients with a controlled viral load appears to be safe, maintains virological suppression, and reduces treatment costs.

Keyphrases

antiretroviral therapy
hiv infected
human immunodeficiency virus
hiv positive
hiv infected patients
hepatitis c virus
hiv aids
hiv testing
south africa
smoking cessation